Telomir Pharmaceuticals Mourns The Passing Of Chairman And CEO Christopher Chapman, Has Named Erez Aminov As A Director, Chairman Of The Board And CEO

+2.08%

-1.65%

Mira Pharmaceuticals Inc Ordinary Shares

MIRA

1.47

+2.08%

Telomir Pharmaceuticals

TELO

1.40

-1.65%

Telomir Board of Directors appoints Erez Aminov as CEO and Chairman of the Board

Telomir also announces Board of Directors departures and additions

TAMPA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of Telomir-1 to promote longevity in humans and dogs through the treatment of age-related conditions, today announced the passing of Chairman of the Board and Chief Executive Officer Christopher Chapman, Jr., M.D. Out of respect and privacy for Dr. Chapman's family, details of his passing will not be made available.

Telomir's Board of Directors has named Erez Aminov, currently Chairman of the Board and Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), as a director, Chairman of the Board and Chief Executive Officer of Telomir.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.